Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
Sanofi announces acquisition of Kadmon
Sanofi announced its acquisition of Kadmon Holdings in a deal valued at $1.9 billion. The article says the purchase was intended to strengthen Sanofi's transplant business line.
2021
FDA approves Rezurock for chronic GVHD
The U.S. Food and Drug Administration approved belumosudil (Rezurock), manufactured by Kadmon Holdings, for patients aged 12 years or older with chronic graft-versus-host disease who have failed at least two previous lines of systemic therapy.